Showing results (931-940 of 1,211) with videos related to

Sort By:
Pageof 122
Circulation|November 19, 2019
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFFelipe A Martinez, Matteo Serenelli, Jose C Nicolau, et al.
European Journal of Heart Failure|January 22, 2022
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HFKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
JAMA Network Open|December 20, 2023
Electronically Delivered Nudges to Increase Influenza Vaccination Uptake in Older Adults With Diabetes: A Secondary Analysis of the NUDGE-FLU TrialMats C Højbjerg Lassen, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMIDouglas L Mann, Johny Nicolas, Brian Claggett, et al.
Circulation|September 28, 2024
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart FailureMuthiah Vaduganathan, Brian L Claggett, Ian J Kulac, et al.
Journal of the American Heart Association|November 19, 2021
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HFLeanne Mooney, Nathaniel M Hawkins, Pardeep S Jhund, et al.
Circulation. Heart Failure|December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection FractionPooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
JAMA Cardiology|November 17, 2024
Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection FractionOrly Vardeny, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 122